NCT00210717View on ClinicalTrials.gov

A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

748

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

April 30, 2007

Conditions
Schizophrenia
Interventions
DRUG

paliperidone palmitate

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210717 - A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia | Biotech Hunter | Biotech Hunter